Basic Stats
| LEI | 549300VFT6WAQB4BVB07 |
| CIK | 1019034 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to BIO-key International, Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 28, 2025 |
Table 1: Newly Registered Securities Calculation of Filing Fee Tables S-8 BIO KEY INTERNATIONAL INC Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0. |
|
| August 28, 2025 |
As filed with the Securities and Exchange Commission on August 28, 2025 Registration No. |
|
| August 27, 2025 |
Table 1: Newly Registered Securities Calculation of Filing Fee Tables S-8 BIO KEY INTERNATIONAL INC Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0. |
|
| August 27, 2025 |
As filed with the Securities and Exchange Commission on August 27, 2025 As filed with the Securities and Exchange Commission on August 27, 2025 Registration No. |
|
| August 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2025 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| August 20, 2025 |
AMENDMENT NO. 1 TO BIO-KEY INTERNATIONAL, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN Exhibit 10.2 AMENDMENT NO. 1 TO BIO-KEY INTERNATIONAL, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN This Amendment No. 1 (the “Amendment”) to the BIO-key International, Inc. 2021 Employee Stock Purchase Plan (the “Plan”) is effective as of August 8, 2025, the date it was approved by the Company’s stockholders. Capitalized terms used but not defined herein have the same meanings as in the Plan. WHEREAS, |
|
| August 20, 2025 |
AMENDMENT NO. 1 TO BIO-KEY INTERNATIONAL, INC. 2023 STOCK INCENTIVE PLAN Exhibit 10.1 AMENDMENT NO. 1 TO BIO-KEY INTERNATIONAL, INC. 2023 STOCK INCENTIVE PLAN This Amendment No. 1 (the “Amendment”) to the BIO-key International, Inc. 2023 Stock Incentive Plan (the “Plan”) is effective as of August 8, 2025, the date it was approved by the Company’s stockholders. Capitalized terms used but not defined herein have the same meanings as in the Plan. WHEREAS, the Company curr |
|
| August 13, 2025 |
Exhibit 99.1 BIO-key Q2’25 Revenue Rose 49% Driven by Increases Across All Three Segments; Launches “BIO-key CyberDefense Initiative” to Support Growing Global Investment in Military and Defense Preparedness; Investor Call 10am ET Today Holmdel, NJ – August 13, 2025 – BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2025 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 1-13463 BIO-KE |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2025 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| June 27, 2025 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under § 240. |
|
| May 15, 2025 |
Exhibit 99.1 BIO-key Reports Q1’25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET Holmdel, NJ – May 15, 2025 – BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authe |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2025 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Number) |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 1-13463 BIO-K |
|
| May 12, 2025 |
Up to 3,091,668 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-286776 Up to 3,091,668 Shares of Common Stock This prospectus relates to the resale, from time to time, by the selling stockholder identified in this prospectus under the caption “Selling Stockholder,” of up to 3,091,668 shares of our common stock, par value $0.0001 per share, issued and sold by us in a private placement transaction, consisting |
|
| May 2, 2025 |
BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 May 2, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, DC 20549 Re: BIO-key International, Inc. - Registration Statement on Form S-1 Commission File No. 333-286776 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of |
|
| April 25, 2025 |
Exhibit 107 Calculation of Filing Fee Table S-1 (Form Type) BIO-key International, Inc. |
|
| April 25, 2025 |
As filed with the Securities and Exchange Commission on April 25, 2025 Registration No. |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2025 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| April 24, 2025 |
BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance Exhibit 99.1 BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance Holmdel, NJ – April 24, 2025 – BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced today that on A |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 1-13463 BIO-KEY I |
|
| April 23, 2025 |
Clawback Policy dated October 2, 2023 Exhibit 97.1 BIO-KEY INTERNATIONAL, INC. CLAWBACK POLICY This BIO-key International, Inc. Clawback Policy (this “Policy”) was approved effective as of October 2, 2023 (the “Effective Date”) by the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of BIO-key International, Inc. (the “Company”). This Policy is adopted pursuant to and intended to comply with Rule 5608 ( |
|
| April 23, 2025 |
Exhibit 19.1 INSIDER TRADING POLICY I. Introduction The purpose of this Insider Trading Policy (this “Policy”) is to promote compliance with applicable United States federal and state securities laws by BIO-key International Inc. (“BIO-key” or the “Company”) and all directors, officers and employees thereof, in order to preserve the reputation and integrity of BIO-key as well as that of persons af |
|
| April 23, 2025 |
List of subsidiaries of BIO-key International, Inc. Exhibit 21.1 Subsidiaries Name State/Country of Incorporation BIO-key Hong Kong Limited Hong Kong Public Safety Group, Inc. Delaware PistolStar, Inc. New Hampshire BIOKEY AFRICA LIMITED Nigeria Swivel Secure Europe, SA Spain Swivel Secure, Unipessoal LDA. Portugal BIO-key Europe SL Spain |
|
| April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐Form 20-F ☐ Form 11-K ☐Form 10-Q ☐Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Perio |
|
| March 27, 2025 |
Exhibit 99.1 BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET Holmdel, NJ – March 27, 2025 – BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring password |
|
| March 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| January 16, 2025 |
Form of Series A Common Stock Purchase Warrant (filed herewith) Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| January 16, 2025 |
Exhibit 10.2 THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED. EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is entered into as of January 15, 2025 by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and BIO- Key International, Inc., a Delaware corporation ( |
|
| January 16, 2025 |
Exhibit 10.3 THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED. EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is entered into as of January 15, 2025 by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and BIO- Key International, Inc., a Delaware corporation ( |
|
| January 16, 2025 |
Form of Series B Common Stock Purchase Warrant (filed herewith) Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| January 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2025 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Nu |
|
| January 16, 2025 |
Exhibit 10.1 BIO-KEY INTERNATIONAL, INC. January 15, 2025 Holder of Warrants Issued in September 2024 Re: Inducement Offer to Exercise Warrants Issued in September 2024 Dear Holder: BIO-key International, Inc., a Delaware corporation (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive new warrants to purchase shares of the Company’s common |
|
| December 3, 2024 |
Exhibit 99.1 BIO-key and Fiber Food Systems Inc. Collaborate to Enhance Security and Efficiency in the Food Tech Sector Transaction Strengthens Balance Sheet with $5M in Assets HOLMDEL, N.J., December 2, 2024 - BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for ph |
|
| December 3, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| December 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| December 3, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of November 27, 2024, among Fiber Food Systems, Inc., a Delaware corporation (“Seller”), BIO-key International, Inc., a Delaware corporation (“Purchaser”) and Boumarang Inc., a Delaware corporation (the “Company”). RECITALS WHEREAS, Seller is the record and beneficial owner of 5 million sha |
|
| November 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| November 15, 2024 |
Exhibit 99.1 BIO-key Reports Q3’24 Revenue Rose 18% to $2.1M, Reduced Q3’24 Net Loss, and Improved Cash Position; Hosts Investor Call Tomorrow, Fri. Nov. 15th, 10am ET Holmdel, NJ – November 14, 2024 – BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity |
|
| November 14, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name o |
|
| November 14, 2024 |
BKYI / BIO-key International, Inc. / ARMISTICE CAPITAL, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| October 25, 2024 |
Up to 2,061,112 Shares of Common Stock FINAL PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-282618 Up to 2,061,112 Shares of Common Stock This prospectus relates to the resale, from time to time, by the selling stockholder identified in this prospectus under the caption “Selling Stockholder,” of up to 2,061,112 shares of our common stock, par value $0.0001 per share, issued and sold by us in a private placement transa |
|
| October 21, 2024 |
BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 October 21, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, DC 20549 Re: BIO-key International, Inc. - Registration Statement on Form S-1 Commission File No. 333-282618 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Ac |
|
| October 11, 2024 |
As filed with the Securities and Exchange Commission on October 11, 2024 Registration No. |
|
| October 11, 2024 |
Exhibit 107 Calculation of Filing Fee Table S-1 (Form Type) BIO-key International, Inc. |
|
| September 16, 2024 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| September 16, 2024 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File |
|
| September 16, 2024 |
BIO-key International Enters into $1.9 Million Warrant Inducement Exhibit 99.1 BIO-key International Enters into $1.9 Million Warrant Inducement HOLMDEL, N.J., Sept. 12, 2024 - BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, today announced it |
|
| September 16, 2024 |
Exhibit 10.1 BIO-KEY INTERNATIONAL, INC. September 12, 2024 Holder of Warrants Issued in October 2023 Re: Inducement Offer to Exercise Warrants Issued in October 2023 Dear Holder: BIO-key International, Inc., a Delaware corporation (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive (i) new warrants to purchase shares of the Company’s comm |
|
| August 28, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| August 15, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| August 15, 2024 |
Exhibit 99.1 BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2’24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET Holmdel, NJ – August 14, 2024 – BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) au |
|
| August 14, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Reg |
|
| July 10, 2024 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under § 240. |
|
| June 28, 2024 |
Exhibit 10.5 GUARANTY This GUARANTY, made effective as of June 24, 2024, is given by PistolStar, Inc., a New Hampshire corporation (“Guarantor”), for the benefit of Streeterville Capital, LLC, a Utah limited liability company, and its successors, transferees, and assigns (collectively “Lender”). PURPOSE A. BIO-key International, Inc., a Delaware corporation and parent of Guarantor (“Borrower”), ha |
|
| June 28, 2024 |
Exhibit 10.4 INTELLECTUAL PROPERTY SECURITY AGREEMENT This INTELLECTUAL PROPERTY SECURITY AGREEMENT (“IP Security Agreement”), dated as of June 24, 2024, is made by BIO-KEY INTERNATIONAL, INC., a Delaware corporation (“Debtor”), in favor of STREETERVILLE CAPITAL, LLC, a Utah limited liability company (the “Secured Party”). A. Debtor issued to Secured Party a certain Secured Promissory Note of even |
|
| June 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| June 28, 2024 |
Exhibit 10.2 SECURED PROMISSORY NOTE Effective Date: June 24, 2024 U.S. $2,360,000.00 FOR VALUE RECEIVED, BIO-key International, Inc., a Delaware corporation (“Borrower”), promises to pay to Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (“Lender”), $2,360,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is eightee |
|
| June 28, 2024 |
Exhibit 10.1 Note Purchase Agreement THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of June 24, 2024, is entered into by and between BIO-KEY INTERNATIONAL, INC., a Delaware corporation (“Company”), and STREETERVILLE CAPITAL, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”). A. Company and Investor are executing and delivering this Agreement in reliance u |
|
| June 28, 2024 |
Exhibit 10.3 Security Agreement THIS SECURITY AGREEMENT (this “Agreement”), dated as of June 24, 2024, is executed by BIO-KEY INTERNATIONAL, Inc., a Delaware corporation (“Debtor”), in favor of STREETERVILLE CAPITAL, LLC, a Utah limited liability company (“Secured Party”). A. Debtor issued to Secured Party a certain Secured Promissory Note of even date herewith, as may be amended from time to time |
|
| June 26, 2024 |
Filing Fee Table (Filed herewith) Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) BIO-key International, Inc. |
|
| June 26, 2024 |
As filed with the Securities and Exchange Commission on June 26, 2024 As filed with the Securities and Exchange Commission on June 26, 2024 Registration No. |
|
| June 20, 2024 |
-12-31FY2023 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| June 17, 2024 |
Exhibit 99.1 Identity and Access Management Software Provider BIO-key Reports Q1’24 Revenue of $2.2M and Positive Operating Cash Flow; Hosts Investor Call Tuesday, 10am ET Holmdel, NJ – June 14, 2024 – BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity |
|
| June 14, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Re |
|
| June 14, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware 1-13463 41-1741861 (State or other jurisdiction of incorporation) (Commission |
|
| June 5, 2024 |
Exhibit 21.1 Subsidiaries Name State/Country of Incorporation BIO-key Hong Kong Limited Hong Kong Public Safety Group, Inc. Delaware PistolStar, Inc. New Hampshire BIOKEY AFRICA LIMITED Nigeria Swivel Secure Europe, SA Spain Swivel Secure, Unipessoal LDA. Portugal BIO-key Europe SL Spain |
|
| June 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 1-13463 BIO-KEY I |
|
| May 24, 2024 |
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq Exhibit 99.1 BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq Wall, NJ – May 24, 2024 – BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on May 22, 2024, it received a letter (the “Notification Letter”) from The Nasdaq S |
|
| May 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Number |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on F |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| April 30, 2024 |
Exhibit 16.1 April 29, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by BIO-key International, Inc. under Item 4.01 of its Form 8-K dated April 23, 2024. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of BIO-key International, Inc |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| April 22, 2024 |
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq Exhibit 99.1 BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq Holmdel, NJ – April 22, 2024 – BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on April 17, 2024, it received a letter (the “Notification Letter”) from The N |
|
| April 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on |
|
| April 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| April 2, 2024 |
Exhibit 99.1 Identity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10am ET Holmdel, NJ – April 1, 2024 – BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless |
|
| February 16, 2024 |
Up to 436,509 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-276773 FINAL PROSPECTUS Up to 436,509 Shares of Common Stock This prospectus relates to the resale, from time to time, by the selling stockholder identified in this prospectus under the caption “Selling Stockholder,” of up to 436,509 shares of our common stock, par value $0.0001 per share, issued and sold by us in a private placement transactio |
|
| February 14, 2024 |
BKYI / BIO-key International, Inc. / ARMISTICE CAPITAL, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 13, 2024 |
EX-99.1 2 exhibit99-1.htm JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of BIO-key International, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to |
|
| February 13, 2024 |
BKYI / BIO-key International, Inc. / Lind Global Fund II LP Passive Investment SC 13G/A 1 sch13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* BIO-key International, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share. (Title of Class of Securities) 09060C507 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appr |
|
| February 8, 2024 |
BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 February 8, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, DC 20549 Re: BIO-key International, Inc. - Registration Statement on Form S-1 Commission File No. 333-276773 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Ac |
|
| January 30, 2024 |
As filed with the Securities and Exchange Commission on January 30, 2024 Registration No. |
|
| January 30, 2024 |
Filing Fee Table (filed herewith) Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) BIO-key International, Inc. |
|
| January 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* BIO-KEY INTERNATIONAL, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 09060C507 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| January 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| December 21, 2023 |
Exhibit 4.2 EXECUTION VERSION NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN |
|
| December 21, 2023 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| December 21, 2023 |
BIO-key Repays $2.2M Senior Secured Note Exhibit 99.1 BIO-key Repays $2.2M Senior Secured Note Holmdel, NJ – December 21, 2023 - BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced today that it has repaid its $2.2M senior secured note in full, e |
|
| December 21, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 20, 2023, between BIO-key International, Inc., a Delaware corporation (the “Company”), and Dillon Hill Investment Company LLC, a Delaware limited liability company (the “Purchaser”). WHEREAS, the Company and the Purchaser are executing this Agreement in reliance upon an exemptio |
|
| December 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| December 19, 2023 |
Exhibit 10.1 BIO-KEY INTERNATIONAL, INC. 2023 STOCK INCENTIVE PLAN (Effective December 14, 2023) 1. Purpose of Plan. The purpose of the BIO-key International, Inc. 2023 Stock Incentive Plan (this “Plan”) is to advance the interests of BIO-key International, Inc., a Delaware corporation (the “Company”), and its stockholders by enabling the Company and its Subsidiaries to attract and retain qualifie |
|
| December 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2023 BIO-key International, Inc. -12-31 (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission |
|
| December 19, 2023 |
Exhibit 99.1 Following Stockholder Approval, BIO-key Announces 1-for-18 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Price Requirement Wall, NJ – December 19, 2023 – BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has app |
|
| December 19, 2023 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF BIO-KEY INTERNATIONAL, INC. Pursuant to Section 242 of the General Corporation Law of the State of Delaware BIO-key International, Inc., a Delaware corporation (the “Corporation”), does hereby certify as follows: FIRST: Upon the effectiveness (the “Effective Time”) pursuant to the General Corporation Law of the State of De |
|
| November 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive |
|
| November 20, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name o |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Nu |
|
| November 2, 2023 |
BIO-key International Announces Pricing of $3.75 Million Public Offering Exhibit 99.1 BIO-key International Announces Pricing of $3.75 Million Public Offering Holmdel, NJ – October 30, 2023 - BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced the pricing of its public of |
|
| November 2, 2023 |
BIO-key International Announces Closing of $3.75 Million Public Offering Exhibit 99.2 BIO-key International Announces Closing of $3.75 Million Public Offering Holmdel, NJ – October 31, 2023 - BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced the closing of its previousl |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Nu |
|
| October 31, 2023 |
Filed Pursuant to Rule 424(b)(4) Registration No. 333-275003 FINAL PROSPECTUS Up to 21,430,000 Units consisting of 21,430,000 Shares of Common Stock or 21,430,000 Pre-Funded Warrants to purchase 21,430,000 Shares of Common Stock and 21,430,000 Common Warrants to purchase up to 21,430,000 Shares of Common Stock Up to 21,430,000 Shares of Common Stock Underlying the Pre-Funded Warrants Up to 21,430, |
|
| October 30, 2023 |
BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 October 30, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, DC 20549 Re: BIO-key International, Inc. Registration Statement on Form S-1 Commission File No. 333-275003 Withdrawal of Request for Acceleration Ladies and Gentlemen: Reference is made t |
|
| October 27, 2023 |
October 27, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-1004 Re: BIO-key International, Inc. Registration Statement on Form S-1, as amended File No. 333-275003 Ladies and Gentlemen: As the placement agent of the proposed offering of BIO-key International, Inc. (the “Company”), we hereby join the Company’s request |
|
| October 27, 2023 |
BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 07733 October 27, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, DC 20549 Re: BIO-key International, Inc. - Registration Statement on Form S-1 Commission File No. 333-275003 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Ac |
|
| October 26, 2023 |
Exhibit 10.39 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of [], 2023, between BIO-key International, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions |
|
| October 26, 2023 |
Form of Placement Agency Agreement Exhibit 1.1 PLACEMENT AGENCY AGREEMENT [], 2023 BIO-key International, Inc. 101 Crawfords Corner Road, Suite 4116 Holmdel, NJ 0773 Attention: Michael DePasquale, Chief Executive Officer Dear Mr. DePasquale: This agreement (the “Agreement”) constitutes the agreement between Maxim Group LLC (the “Placement Agent”) and BIO-key International, Inc., a Delaware corporation (the “Company”), pursuant to w |
|
| October 26, 2023 |
As filed with the Securities and Exchange Commission on October 25, 2023 Registration No. |
|
| October 26, 2023 |
Exhibit 4.10 PRE-FUNDED COMMON STOCK PURCHASE WARRANT BIO-KEY INTERNATIONAL, INC. Warrant Shares: Initial Exercise Date: , 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the dat |
|
| October 26, 2023 |
Exhibit 4.9 COMMON STOCK PURCHASE WARRANT BIO-KEY INTERNATIONAL, INC. Warrant Shares: Initial Exercise Date: , 2023 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial |
|
| October 26, 2023 |
Exhibit 4.11 WARRANT AGENCY AGREEMENT WARRANT AGENCY AGREEMENT (“Warrant Agreement”) made as of [] (“Issuance Date”), between BIO-key International, Inc., a Delaware corporation, with offices at 3349 Highway 138, Building A, Suite E, Wall, NJ 07719 (“Company”), and Broadridge Corporate Issuer Solutions, Inc., with offices at 51 Mercedes Way, Edgewood, NY 11717 (“Warrant Agent”). WHEREAS, the Compa |
|
| October 25, 2023 |
Exhibit 99.1 Digital Authentication and Identity Provider BIO-key Sees Q3 Revenues Rising over 30% to $1.8M on Strength in Software License Fees, Services and Hardware Sales Holmdel, NJ – October 25, 2023 - BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Boun |
|
| October 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Nu |
|
| October 16, 2023 |
As filed with the Securities and Exchange Commission on October 16, 2023 Registration No. |
|
| October 16, 2023 |
Filing Fee Table (filed herewith) Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) BIO-key International, Inc. |
|
| August 18, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Reg |
|
| August 15, 2023 |
Exhibit 99.1 Identity and Access Management Provider BIO-key Reports Q2 Revenue of $1.9M; Hosts Investor Call Tomorrow, August 15th at 10am ET WALL, NJ – August 14, 2023 - BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today reported results for its second quarter ended |
|
| August 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| August 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form |
|
| July 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| July 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| June 27, 2023 |
Exhibit 10.1 WAIVER AND AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT This Waiver and Amendment No. 1 and Waiver to that certain Securities Purchase Agreement (the “Agreement”), dated as of December 22, 2022, by and between Bio-key International, Inc., a Delaware corporation, with headquarters located at 3349 Highway 138, Building A, Suite E, Wall, NJ 07719 (the “Company”), and AJB Capital Inve |
|
| June 22, 2023 |
BIO-key International, Inc. 3349 Highway 138, Building A, Suite E Wall, NJ 07719 BIO-key International, Inc. 3349 Highway 138, Building A, Suite E Wall, NJ 07719 June 22, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, DC 20549 Re: BIO-key International, Inc. - Registration Statement on Form S-1 Commission File No. 333-272675 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1 |
|
| June 15, 2023 |
As filed with the Securities and Exchange Commission on June 15, 2023 Registration No. |
|
| June 15, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) BIO-key International, Inc. |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| June 9, 2023 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under § 240. |
|
| June 9, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of registrant as specified |
|
| June 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Number |
|
| June 1, 2023 |
Exhibit 21.1 Subsidiaries Name State/Country of Incorporation BIO-key Hong Kong Limited Hong Kong Public Safety Group, Inc. Delaware PistolStar, Inc. New Hampshire BIOKEY AFRICA LIMITED Nigeria Swivel Secure Europe, SA Spain Swivel Secure, Unipessoal LDA. Portugal BIO-key Europe SL Spain |
|
| June 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 1-13463 BIO-KEY INTERNATIONAL, INC. |
|
| May 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Number |
|
| May 30, 2023 |
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq Exhibit 99.1 BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq Wall, NJ – May 30, 2023 – BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on May 23, 2023, it received a letter (the “Notification Letter”) from The Nasdaq S |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on For |
|
| May 16, 2023 |
Exhibit 99.1 Identity and Access Management Provider BIO-key’s Q1 Revenue Rose 59% Driven by Growing Recurring Revenue Base and New Customer Wins; Investor Call 10am ET Today WALL, NJ – May 16, 2023 - BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today reported record |
|
| May 16, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Number |
|
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| April 24, 2023 |
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq Exhibit 99.1 BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq Wall, NJ – April 24, 2023 – BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on April 18, 2023, it received a letter (the “Notification Letter”) from The Nasd |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| March 31, 2023 |
NT 10-K 1 bkyi20230331nt10k.htm FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transitio |
|
| March 31, 2023 |
Exhibit 99.1 Cybersecurity Solutions Provider BIO-key’s 2022 Revenues Increased 37% to $7.0M Reflecting Growing Base of Annual Recurring Revenue; Investor Call Today at 10am ET Expects record quarterly revenue in Q1 2023 WALL, NJ – March 31, 2023 - BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access management (IAM) and Identity-Bound B |
|
| March 31, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| February 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Nu |
|
| January 13, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2023 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Nu |
|
| January 10, 2023 |
BKYI / BIO-key International, Inc. / AJB Capital Investments LLC - SCHEDULE 13G Passive Investment SC 13G 1 sc13g.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* BIO-KEY INTERNATIONAL, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 09060C4087 (CUSIP Number) December 22, 2022 (Date of Event Which Requires Filing of this Statement) Check |
|
| January 10, 2023 |
EX-99 2 ex99-1.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendmen |
|
| December 23, 2022 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS PROMISSORY NOTE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT |
|
| December 23, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of December 22, 2022, by and between BIO-KEY INTERNATIONAL, INC., a Delaware corporation, with headquarters located at 3349 Highway 138, Building A, Suite E, Wall, NJ 07719 (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sherida |
|
| December 23, 2022 |
Exhibit 10.4 SECURITY AGREEMENT This SECURITY AGREEMENT (this ?Agreement?) made and effective as of December 22, 2022, is executed by and between BIO-KEY INTERNATIONAL, INC., a Delaware corporation (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company (the ?Secured Party?). WHEREAS, pursuant to a Securities Purchase Agreement dated as of the date hereof, between t |
|
| December 23, 2022 |
Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| December 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| November 15, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| November 15, 2022 |
Exhibit 99.1 Cyber-Security Provider BIO-key Reports Q3 and Year-to-Date Revenues Rose to $1.4M and $5.3M, Respectively, on Growing Software and Services Revenue; Investor Call Tomorrow at 10am ET WALL, NJ ? November 14, 2022 - BIO-key? International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) and large-scale identity solutions, featu |
|
| November 14, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Registrant as Sp |
|
| August 17, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Registrant as Specifi |
|
| August 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ?Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on For |
|
| August 12, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| August 12, 2022 |
Exhibit 99.1 Identity and Access Management Cyber-Security Provider BIO-key?s Q2 Revenue Rises 96% to $1.9M, Driven by Growth in Software, Services and Products; Investor Call Today at 10am ET WALL, NJ ? August 12, 2022 - BIO-key? International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) and large-scale identity solutions, featuring I |
|
| July 26, 2022 |
Exhibit 16.1 July 26, 2022 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Dear Commissioners: We have read the statements made by BIO-key International, Inc. (the ?Company?), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of the Company dated July 26, 2022 and are in agreement with |
|
| July 26, 2022 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware 1-13463 41-1741861 (State or other jurisdiction of (Commission File Number) ( |
|
| June 27, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| May 23, 2022 |
Exhibit 10.1 MANAGEMENT SERVICES AGREEMENT THIS MANAGEMENT SERVICES AGREEMENT (this ?Agreement?) is made as of March 8, 2022 (the ?Effective Date?), by and among Swivel Aman ? FZCO, a United Arab Emirates Free Zone Company (the ?Company?), Swivel Secure Europe, S.A., a company incorporated under the laws of Spain (Company No. ES A87886347) (the ?Provider?), and Alex Rocha (?Rocha? and, together wi |
|
| May 23, 2022 |
Exhibit 10.2 OPTION AGREEMENT This Option Agreement is made and entered into this 8th day of March, 2022, by and between BIO-key International, Inc., a Delaware corporation (the ?Buyer?), and Alex Rocha (the ?Seller?). RECITALS A. Buyer, Seller, and Swivel Secure Europe, S.A., a company incorporated under the laws of Spain (Company No. ES A87886347) (?Swivel Secure?), are parties to that certain S |
|
| May 23, 2022 |
Exhibit 10.3 SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE SUCH TERMS ARE NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH THREE ASTERISKS (***) DATED 23 October 2020 (1) SWIVEL SECURE LIMITED and (2) SWIVEL SECURE EUROPE S.A. DISTRIBUTOR AGREEMENT THIS AGREEMENT is dated and is made BETWEEN: (1) SWIVEL SEC |
|
| May 23, 2022 |
Exhibit 10.4 SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE SUCH TERMS ARE NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH THREE ASTERISKS (***) DEED OF VARIATION THIS DEED OF VARIATION is dated 26 January 2022 and made BETWEEN: (1) SWIVEL SECURE LIMITED, a company incorporated in England with registered nu |
|
| May 23, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of registrant as specified |
|
| May 16, 2022 |
NT 10-Q 1 bkyi20220516nt10q.htm FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐Form 10-K ☐Form 20-F ☐Form 11-K ☒Form 10-Q ☐Form 10-D ☐Form N-SAR ☐Form N-CSR For Period Ended: March 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| May 16, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Number |
|
| May 16, 2022 |
Exhibit 99.1 Identity and Access Management Cyber-Security Provider BIO-key?s Q1 Revenue Improved to $1.9M, Driven by 205% Increase in Software License Fees; Investor Call Today at 10am ET WALL, NJ ? May 16, 2022 - BIO-key? International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) an |
|
| May 5, 2022 |
DEF 14A 1 bkyi20220503def14a.htm FORM DEF 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definit |
|
| April 1, 2022 |
List of subsidiaries of BIO-key International, Inc. Exhibit 21.1 Subsidiaries Name State/Country of Incorporation BIO-key Hong Kong Limited Hong Kong Public Safety Group, Inc. Delaware PistolStar, Inc. New Hampshire BIOKEY AFRICA LIMITED Nigeria Swivel Secure Europe, SA Spain Swivel Secure, Unipessoal LDA. Portugal |
|
| April 1, 2022 |
NT 10-K 1 bkyi20220331nt10k.htm FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transitio |
|
| April 1, 2022 |
Exhibit 4.5 BIO-KEY INTERNATIONAL, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 BIO-key International, Inc., a Delaware corporation (?we,? ?us? and ?our?), has only one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, $0.0001 par value per share (?common stock?). Common S |
|
| April 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 1-13463 BIO-KEY INTERNATIONAL, INC. |
|
| March 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| March 29, 2022 |
Exhibit 99.1 Identity and Access Management Security Provider BIO-key?s 2021 Revenue Rose 80% to $5.1M, Driven by Demand for Identity-as-a-Service Cloud Solutions; Investor Call Today at 10am ET WALL, NJ ? March 29, 2022 - BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics ( |
|
| March 9, 2022 |
Exhibit 2.1 AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT This Amendment No. 1 to that certain Stock Purchase Agreement (the ?Agreement?) dated February 2, 2022 by and among Alex Rocha (the ?Seller?), BIO-key International, Inc., a Delaware corporation (the ?Buyer?), and Swivel Secure Europe, S.A., a company incorporated under the laws of Spain (Company No. ES A87886347) (the ?Company?), is made and |
|
| March 9, 2022 |
Exhibit 99.1 BIO-key Completes Acquisition of Swivel Secure Europe, Significantly Expanding its Revenue Base, Customer Reach and Talent in Europe, Middle East and Africa Madrid, Spain & Wall, NJ ? March 9, 2022 - BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) and Identity-Bound Biometric (IBB) solutions, today annou |
|
| March 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| February 11, 2022 |
BKYI / BIO-key International, Inc. / Lind Global Macro Fund LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* BIO-key International, Inc. (Name of Issuer) Common Stock, par value $.0001 per share. (Title of Class of Securities) 09060C408 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 3, 2022 |
Exhibit 2.1 STOCK PURCHASE AGREEMENT AMONG ALEX ROCHA, BIO-KEY INTERNATIONAL, INC., AND SWIVEL SECURE EUROPE, S.A. DATED FEBRUARY 2, 2022 Exhibits and Schedules Exhibit A- Form of Rocha Employment Agreement Exhibit B- Form of UAE Sub Option Agreement Exhibit C - Form of UAE Sub Management Agreement Company Disclosure Schedules STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this ?Agreement |
|
| February 3, 2022 |
Exhibit 99.1 BIO-key to Significantly Expand Customer Reach and Talent in EMEA Region via Definitive Agreement to Acquire Authentication Solutions Provider Swivel Secure Europe Wall, NJ ? February 3, 2022 - BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced t |
|
| February 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2022 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Nu |
|
| November 16, 2021 |
Exhibit 99.1 Identity, Security & Access Control Provider BIO-key Reports Q3 Revenue Growth of 38% Year-over-Year and 31% Sequentially Driven by Increased IDentity-as-a-Service Cloud Revenue; Investor Call Tomorrow at 10am ET WALL, NJ ? November 15, 2021 - BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions fea |
|
| November 16, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2021 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Registr |
|
| August 17, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| August 17, 2021 |
EX-99.1 2 ex276492.htm EXHIBIT 99.1 Exhibit 99.1 Identity & Access Management (IAM) Solutions Provider BIO-key Reports Increased Revenue and Reduced Net Loss on Growth in Cloud ID-as-a-Service (IDaaS); Investor Call Tomorrow at 10am ET WALL, NJ – August 16, 2021 - BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and multi-factor identity and access management (IAM) s |
|
| August 16, 2021 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Registrant as Specifi |
|
| July 15, 2021 |
BIO-key International, Inc. 3349 Highway 138, Building A, Suite E Wall, NJ 07719 BIO-key International, Inc. 3349 Highway 138, Building A, Suite E Wall, NJ 07719 July 15, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, DC 20549 Re: BIO-key International, Inc. - Registration Statement on Form S-3 Commission File No. 333-257875 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1 |
|
| July 13, 2021 |
As filed with the Securities and Exchange Commission on July 13, 2021 Table of Contents As filed with the Securities and Exchange Commission on July 13, 2021 Registration No. |
|
| July 8, 2021 |
As filed with the Securities and Exchange Commission on July 7, 2021 As filed with the Securities and Exchange Commission on July 7, 2021 Registration No. |
|
| June 29, 2021 |
As filed with the Securities and Exchange Commission on June 29, 2021 As filed with the Securities and Exchange Commission on June 29, 2021 Registration No. |
|
| June 21, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2021 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| May 17, 2021 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of registrant as specified |
|
| May 14, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2021 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Number |
|
| May 14, 2021 |
Exhibit 99.1 Identity & Access Management Solutions Provider BIO-key?s Q1 Revenues Improved to $1.9M versus $0.5M in Q1?20 and $1.1M in Q4; Investor Call Today at 10am ET WALL, NJ ? May 14, 2021 - BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and multi-factor identity and access management (IAM) solutions for strong, convenient user authentication and large-scale |
|
| May 4, 2021 |
SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to ss. |
|
| April 16, 2021 |
As filed with the Securities and Exchange Commission on April 16, 2021 Registration No. |
|
| March 29, 2021 |
Exhibit 10.42 EMPLOYMENT AGREEMENT THIS AGREEMENT (the "Agreement") dated April 5, 2017 by and between BIO-Key International, Inc., a Delaware corporation with its principal place of business at 3349 Highway 138, Building D, Suite A, Wall NJ 07719 (the "Company") and James Sullivan, at 410 Hampton View Court, Milton, Georgia 30004 (the "Executive"). WITNESSETH: WHEREAS, the Company desires to secu |
|
| March 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 1-13463 BIO-KEY INTERNATIONAL, INC. |
|
| March 29, 2021 |
List of subsidiaries of BIO-key International, Inc. Exhibit 21.1 Subsidiaries Name State/Country of Incorporation BIO-key Hong Kong Limited Hong Kong Public Safety Group, Inc. Delaware PistolStar, Inc. New Hampshire BIOKEY AFRICA LIMITED Nigeria |
|
| March 25, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2021 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numb |
|
| March 25, 2021 |
Exhibit 99.1 Identity and Access Management Solutions Provider BIO-key’s Q4 Revenues Doubled to $1.1M and 2020 Revenues Rose 25% to $2.8M; Enters 2021 with $17M in Cash to Support Global Growth Initiatives; Investor Call Today at 10am ET WALL, NJ – March 25, 2021 - BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and multi-factor identity and access management (IAM) |
|
| March 9, 2021 |
Shareholder Director Nominations UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2021 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| February 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* BIO-key International, Inc. (Name of Issuer) Common Stock, par value $.0001 per share. (Title of Class of Securities) 09060C4087 (CUSIP Number) December 31, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designa |
|
| November 19, 2020 |
Exhibit 99.1 Following Approval at its Special Meeting of Shareholders, BIO-key Announces 1-for-8 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Price Requirement WALL, NJ – November 19, 2020 - BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and other multi-factor identity and access management (IAM) solutions for strong, convenient authentication |
|
| November 19, 2020 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF BIO-KEY INTERNATIONAL, INC. Pursuant to Section 242 of the General Corporation Law of the State of Delaware BIO-key International, Inc., a Delaware corporation (the “Corporation”), does hereby certify as follows: FIRST: Upon the effectiveness (the “Effective Time”) pursuant to the General Corporation Law of the State of De |
|
| November 19, 2020 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| November 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Registr |
|
| November 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| November 12, 2020 |
Exhibit 99.1 Biometric and Multi-Factor Identity and Access Management Provider BIO-key Reports Q3 Revenue of $943K and $18.4M Cash Position; Hosts Investor Webcast Today at 10am ET WALL, NJ – November 12, 2020 - BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and other multi-factor identity and access management (IAM) solutions for strong, convenient user authentic |
|
| October 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| October 2, 2020 |
PRE 14A 1 bkyi20201001pre14a.htm FORM PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for use of the Commission only (as permitted |
|
| September 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File N |
|
| August 28, 2020 |
Exhibit 10.1 RESTRICTED STOCK AWARD AGREEMENT THIS AGREEMENT is entered into and effective as of August 25, 2020 (the “Date of Grant”), by and between BIO-key International, Inc. (the “Company”) and [NAME] (the “Grantee”). A. The Company has adopted the BIO-key International, Inc. Amended & Restated 2015 Equity Incentive Plan (the “Plan”) authorizing the grant of Restricted Stock Awards to employe |
|
| August 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| August 14, 2020 |
Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Reg |
|
| August 14, 2020 |
Exhibit 99.1 BIO-key Reports Q2 Results and a Post-Recapitalization Cash Position of Approximately $18M - Investor Webcast Today at 10am ET WALL, NJ – August 14, 2020 - BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and other multi-factor identity and access management (IAM) solutions for strong, convenient user authentication and large-scale identity applications, |
|
| August 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| August 7, 2020 |
Submission of Matters to a Vote of Security Holders 8-K 1 bkyi202008068k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporat |
|
| August 3, 2020 |
BKYI / BIO-key International, Inc. / INTRACOASTAL CAPITAL, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* BIO-key International, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 09060C309 (CUSIP Number) July 23, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| July 28, 2020 |
BIO-key International, Inc. and Subsidiaries Exhibit 99.3 The following proforma financial statements of BIO-key International, Inc. are included herein at the indicated page numbers: Unaudited Pro Forma Condensed Combined Statement of Operations Year Ended December 31, 2019 F-2 Unaudited Pro Forma Condensed Combined Statement of Operations Three Months Ended March 31, 2020 F-3 Unaudited Pro Forma Condensed Combined Balance Sheet as of March |
|
| July 28, 2020 |
PistolStar, Inc. BALANCE SHEET EX-99.2 4 ex195344.htm EXHIBIT 99.2 Exhibit 99.2 PistolStar, Inc. BALANCE SHEET (Unaudited) March 31, 2020 ASSETS Cash and cash equivalents $ 513,214 Accounts receivable, net 196,138 Prepaid expenses and other 10,383 Total current assets 719,735 Equipment and leasehold improvements, net 41,785 Deposits and other assets 194,326 Total non-current assets 236,111 TOTAL ASSETS $ 955,846 LIABILITIES Acc |
|
| July 28, 2020 |
EX-99.1 3 ex195343.htm EXHIBIT 99.1 Exhibit 99.1 The following financial statements of PistolStar, Inc. are included herein at the indicated page numbers: Independent Auditor’s Report 2019 F-2 Balance Sheet—December 31, 2019 F-3 Statement of Income and Retained Earnings—Year ended December 31, 2019 F-4 Statement of Cash Flows—Year ended December 31, 2019 F-5 Notes to the Financial Statements—Decem |
|
| July 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| July 28, 2020 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Num |
|
| July 23, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-13463 (Commission File Numbe |
|
| July 23, 2020 |
BIO-key Announces Pricing of Upsized $21.6 Million Underwritten Public Offering Exhibit 99.1 BIO-key Announces Pricing of Upsized $21.6 Million Underwritten Public Offering Wall, NJ, July 20, 2020 - BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of biometric authentication and security solutions, announced today the pricing of an underwritten public offering of 33,230,000 shares of its common stock (or pre-funded warrants to purchase common stock in lieu t |
|
| July 22, 2020 |
Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-239782 29,130,000 Shares of Common Stock Pre-Funded Warrants to Purchase up to 4,100,000 Shares of Common Stock Warrants to Purchase up to 33,230,000 Shares of Common Stock We are offering 29,130,000 shares of common stock and warrants to purchase up to 33,230,000 shares of our common stock at a combined public offering price |
|
| July 20, 2020 |
As filed with the Securities and Exchange Commission on July 20, 2020 Registration No. |
|
| July 20, 2020 |
Form of Warrant Agency Agreement* Exhibit 4.4 WARRANT AGENCY AGREEMENT WARRANT AGENCY AGREEMENT (“Warrant Agreement”) made as of [] (“Issuance Date”), between BIO-key International, Inc., a Delaware corporation, with offices at 3349 Highway 138, Building A, Suite E, Wall, NJ 07719 (“Company”), and Broadridge Corporate Issuer Solutions, Inc., with offices at 51 Mercedes Way, Edgewood, NY 11717 (“Warrant Agent”). WHEREAS, the Compan |
|
| July 20, 2020 |
Table of Contents As filed with the Securities and Exchange Commission on July 17, 2020 Registration No. |
|
| July 17, 2020 |
Exhibit 1.1 SHARES of Common Stock, PRE-FUNDED warrants (exercisable for Shares) and Warrants (exercisable for Shares) of BIO-key International, Inc. UNDERWRITING AGREEMENT July [], 2020 Maxim Group LLC Investment Banking 405 Lexington Avenue, 2nd Fl. New York, NY 10174 As Representative of the Several underwriters, if any, named in Schedule I hereto Ladies and Gentlemen: The undersigned, BIO-key |
|
| July 17, 2020 |
Exhibit 4.2 Exhibit B-2 PRE-FUNDED COMMON STOCK PURCHASE WARRANT BIO-key International, Inc. Warrant Shares: Initial Exercise Date: , 2020 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or af |
|
| July 17, 2020 |
Exhibit 4.3 Exhibit B-1 COMMON STOCK PURCHASE WARRANT BIO-key International, Inc. Warrant Shares: Initial Exercise Date: , 2020 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (t |
|
| July 17, 2020 |
July 17, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| July 17, 2020 |
Table of Contents As filed with the Securities and Exchange Commission on July 16, 2020 Registration No. |
|
| July 17, 2020 |
CORRESP 1 filename1.htm BIO-key International, Inc. 3349 Highway 138, Building A, Suite E Wall, NJ 07719 July 17, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, DC 20549 Re: BIO-key International, Inc. - Registration Statement on Form S-1 Commission File No. 333-239782 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under |
|
| July 9, 2020 |
As filed with the Securities and Exchange Commission on July 9, 2020 Registration No. |
|
| July 9, 2020 |
Exhibit 21.1 Subsidiaries Name State of Incorporation BIO-key Hong Kong Limited Hong Kong Public Safety Group, Inc. Delaware PistolStar, Inc. New Hampshire |
|
| July 7, 2020 |
Exhibit 2.1 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this “Agreement”), dated as of June 6, 2020 is entered into by and among Thomas J. Hoey (“Seller”), BIO-key International, Inc., a Delaware corporation (“Buyer”) and PistolStar, Inc., a New Hampshire corporation (the “Company”). RECITALS WHEREAS, Seller owns all of the issued and outstanding shares of common stock, no par value (t |
|
| July 7, 2020 |
8-K 1 bkyi202007068k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2020 BIO-key International, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporati |
